Aquestive Therapeutics, Inc. (AQST): Weighted Average Diluted Shares
106.93M
Year ended 2025-12-31
+29.9%
3-year compound annual growth
+26.0%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 106.93M | +23.3% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | 86.73M | +41.6% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | 61.26M | +25.7% | 2025-03-05, From 2023-01-01 |
| 2022-12-31 | 48.73M | +28.0% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | 38.08M | +13.2% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | 33.65M | n/a | 2022-03-08, From 2020-01-01 |